Teriflunomide for treating relapsing–remitting multiple sclerosis

Technology appraisal guidance
Reference number: TA303
Published: 22 January 2014
Last updated: 01 June 2014

Multiple sclerosis (relapsing) - teriflunomide: final appraisal determination

Multiple sclerosis (relapsing) - teriflunomide: final appraisal determination

Multiple sclerosis (relapsing) - teriflunomide: final appraisal determination
06 December 2013
(218.35 Kb 3 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 05 December 2013